We revealed, in mdx/IL6 mice, a progressive reduction of the Nrf2-dependent antioxidant compensatory mechanism, a severe phenotypic feature observed in human DMD patients [11]. This evidence concerns the gene NFE2L2 and Duchenne muscular dystrophy.